The authors examined the relation between time since onset of illicit drug injection (time at
risk) and rates of hepatitis C virus (HCV) infection by using meta-regression. In 72 …

Abstract Background and Aims People who have recently injected drugs are a priority
population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the …

Abstract Changes in hepatitis C virus (HCV) prevalence from 1992 to 2006 were examined
by using 24,311 records from unlinked anonymous surveillance of injecting drug users in …

Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To
examine the prevalence and incidence of these infections over a 20-year period (1985 …

Early acquisition of hepatitis C virus (HCV) infection appears to affect a substantial
proportion of injection drug users (IDUs)—between 20 percent and 90 percent. Analysing …

Objective. To examine hepatitis C virus (HCV) seroprevalence among injection drug users in
4 US cities from 1994 through 2004. Methods. Demographic characteristics, behaviors, and …

This study aimed to investigate the prevalence and correlates of hepatitis C virus infection
among injecting drug users in a community-based setting in Tehran, Iran. In October 2004 …

Background: Beginning in 1994, Vancouver experienced an explosive outbreak of HIV
infection among injection drug users (IDUs). The objectives of this study were to measure …

STUDY OBJECTIVE: To review the epidemiology of hepatitis C virus (HCV) infection among
injecting drug users (IDUs) in Australia, and consider needs for further research and …

BACKGROUND & AIMS: Our aim was to estimate the rate of progression to cirrhosis for
those infected with hepatitis C virus (HCV) through injection drug use. METHODS: We …